Xylazine presents new challenges for emergency treatment of overdose
Protocols for first responders and harm reduction workers should be reviewed and updated to account for the increased presence of the animal tranquilizer xylazine in the illicit street drug supply, according to a new study led by researchers at the Yale School of Public Health.
Opara receives $3.5 million grant to curb urban drug use, involve youth in research
Yale School of Public Health Associate Professor Ijeoma Opara has received the NIDA (National Institute on Drug Abuse) Racial Equity Visionary Award. The award is a NIDA DP1 grant for $3.5 million over five years that will allow her to work within predominantly urban neighborhoods to curb substance use among racial/ethnic minorities.
Highlighting Gender-based Differences in Alcohol-associated Hepatitis
During her Yale School of Medicine fellowships in gastroenterology and transplant hepatology, Anahita Rabiee, MD, MHS, instructor of medicine (digestive diseases), saw a lot of men and women admitted with alcohol-associated hepatitis—the most severe form of alcohol-related liver disease—at Yale New Haven Hospital. At the time, she couldn’t help noticing that women with this condition tended to have worse outcomes than men.
Teens with addiction are often left to detox without medication
Teens who land in emergency rooms with an opioid overdose generally receive naloxone to reverse the effects of dangerous drugs in their system and are sent home with a list of places they can go for follow-up care. But too often, those teens never seek additional help. They are left to suffer through the agony of withdrawal with no medications to ease their cravings. As a result, many, seeking relief, go back to opioids, often with tragic consequences.Source: CNN Health
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
Many Ukrainian refugees fleeing the war have encountered obstacles when seeking therapies for opioid use disorder in European Union countries, a new Yale-led study finds. The study examines the barriers to opioid agonist therapies (OAT) and providers’ responses to increased demand in OAT enrollment.
The Importance of Considering Sex and Gender in Tobacco Regulation
In a recent JAMA Viewpoint, three Yale Psychiatry faculty members showcase why a greater focus on sex and gender differences in FDA regulatory action on tobacco is essential to public health. They highlight specific tobacco regulations under consideration by FDA and offer approaches as to how the impact of sex and gender can be integrated into regulatory actions.
Saving Lives: YSPH students receive training on overdose response
On February 9th, 2023, 91 Yale School of Public Health students gathered in Winslow Auditorium for training on overdose prevention and response. Overdose training is considered an important skill for future public health practitioners and community workers.
Why 25? Doctors warn against the negative impact of cannabis use on young adult brains
Cannabis is now decriminalized in Connecticut for people 21 and older. Drs. Deepa Camenga & Deepak (Cyril) D'Souza speak on the risks and implications of recreational cannabis use before the age of 25.Source: Connecticut Public Radio
Six CT toddlers died from Fentanyl in 2021. Its potency and a spike in illicit use have child advocates worried what’s to come.
Dr. Deepa Camenga, associate professor of emergency medicine, pediatrics and public health at the Yale School of Medicine, shares how children and teens find themselves coming in contact with fentanyl as accidental overdoses rise.Source: Hartford Courant
Survey Shows Most Physicians Favor Allowing Telehealth to Treat Opioid-use Disorder
A survey of more than 1,000 registered physicians who used telehealth services to treat patients with opioid-use disorder during COVID-19 found that an overwhelming majority favor making telehealth a permanent part of their practice.
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
COVID-19 patients with substance use disorders had greater likelihood of requiring critical interventions, such as ICU admission and ventilatory support. Substance use disorders and psychiatric diagnoses were also associated with a longer duration of hospitalization and greater number of hospital admissions.Source: The Journal of Clinical Psychiatry